Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01465425 | Extracolonic Findings on Computed Tomography (CT) Colonography(ACRIN7151) | unknown | — | 520 | American College of Radiology Imaging NetworkNETWORK | 0 | Oct 11, 2018 | clinicaltrials |
| NCT03398291 | Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy | unknown | Phase 3 | 300 | Fudan UniversityOTHER | 1 | Oct 9, 2018 |
| clinicaltrials |
| NCT03690323 | Pancreatic Locally Advanced Irresectable Cancer Ablation(PELICAN) | unknown | N/A | 228 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Oct 1, 2018 | clinicaltrials |
| NCT03687853 | Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery | unknown | N/A | 80 | Peking University Third HospitalOTHER | 1 | Sep 27, 2018 | clinicaltrials |
| NCT03685370 | PERiX: Comparison of Efficacy Between Placement of Epidural Catheters X-ray Guided and LOS Technique(PERiX) | unknown | N/A | 154 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Sep 26, 2018 | clinicaltrials |
| NCT03679910 | Evaluation of CEMIP in Pancreatic Cancer | unknown | — | 90 | Assiut UniversityOTHER | 1 | Sep 21, 2018 | clinicaltrials |
| NCT03662035 | Apatinib Combined With S-1 in the Second-line Treatment of Advanced Pancreatic Cancer(ASPC) | unknown | Phase 2 | 30 | Changzhou No.2 People's HospitalOTHER | 0 | Sep 19, 2018 | clinicaltrials |
| NCT03668418 | Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos(xenoZ) | unknown | — | 120 | University of PisaOTHER | 1 | Sep 12, 2018 | clinicaltrials |
| NCT03642093 | HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery(HOPE) | unknown | Phase 4 | 60 | Siobhan TrotterOTHER | 1 | Sep 11, 2018 | clinicaltrials |
| NCT03665571 | Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic Cancer | unknown | — | 100 | Asan Medical CenterOTHER | 1 | Sep 11, 2018 | clinicaltrials |
| NCT03662412 | Study of Sirolimus in Patients With Advanced Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 36 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Sep 7, 2018 | clinicaltrials |
| NCT03659292 | Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal Pancreatectomy | unknown | N/A | 540 | Fudan UniversityOTHER | 1 | Sep 6, 2018 | clinicaltrials |
| NCT02450656 | Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer(M14AFS) | unknown | Phase 1 / Phase 2 | 320 | The Netherlands Cancer InstituteOTHER | 1 | Aug 27, 2018 | clinicaltrials |
| NCT03633734 | Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma | unknown | Phase 1 / Phase 2 | 49 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT03228095 | Volatiles in Breath and Headspace Analysis - Diagnostic Markers(Volatolome) | unknown | — | 3,000 | University of LatviaOTHER | 1 | Aug 21, 2018 | clinicaltrials |
| NCT03636308 | Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer(ASAGPAC) | unknown | Phase 2 | 40 | Peking UniversityOTHER | 1 | Aug 17, 2018 | clinicaltrials |
| NCT02975141 | Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer(AFFECT) | unknown | Phase 1 | 12 | PD Dr. med. Volker HeinemannOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT03621852 | Prospective Evaluation of the Diagnostic Efficacy of a EUS Guided FNB Needle (AQUIRE®) | unknown | — | 40 | Philipps University MarburgOTHER | 1 | Aug 9, 2018 | clinicaltrials |
| NCT03607643 | A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies | unknown | Phase 1 / Phase 2 | 160 | Leaf Vertical Inc.INDUSTRY | 1 | Jul 31, 2018 | clinicaltrials |
| NCT03570502 | Incidence of POPF in the Resection of the Left Pancreas With RFAT(RFATPancreas) | unknown | — | 38 | Hospital del MarOTHER | 1 | Jun 27, 2018 | clinicaltrials |
| NCT03460925 | Improving REsectability in Pancreatic NEoplasms (IRENE)(IRENE) | unknown | N/A | 14 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT03513198 | Perfusion Assessment With Contrast-Enhanced EUS in Locally Advanced and Metastatic Pancreatic Cancer(PEACE) | unknown | — | 200 | University of Medicine and Pharmacy CraiovaOTHER | 0 | May 1, 2018 | clinicaltrials |
| NCT03502343 | Efficacy and Safety of Modified Nab-Paclitaxel Plus Gemcitabine Chemotherapy for Metastatic Pancreatic Cancer | unknown | Phase 2 | 52 | Yonsei UniversityOTHER | 1 | Apr 18, 2018 | clinicaltrials |
| NCT03497819 | Autologous CARTmeso/19 Against Pancreatic Cancer | unknown | Early Phase 1 | 10 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Apr 13, 2018 | clinicaltrials |
| NCT03366038 | Shark Mouth Modified Pancreaticojejunostomy(SMMP) | unknown | — | 120 | Peking University Third HospitalOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT02758587 | Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) | unknown | Phase 1 / Phase 2 | 59 | NHS Greater Glasgow and ClydeOTHER | 1 | Mar 19, 2018 | clinicaltrials |
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | unknown | Phase 1 | 34 | Merrimack PharmaceuticalsINDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
| NCT03443921 | Divestment for Artery-involved Pancreatic Cancer | unknown | N/A | 122 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 23, 2018 | clinicaltrials |
| NCT03435770 | Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms | unknown | N/A | 10 | Singapore General HospitalOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT03435289 | A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer | unknown | Phase 1 | 24 | Atlantic Health SystemOTHER | 1 | Feb 19, 2018 | clinicaltrials |
| NCT03417843 | Safety and Efficacy of an Ablation Catheter for the Treatment of Pancreatic Premalignant Cyctic Lesions.(yes) | unknown | N/A | 20 | HaEmek Medical Center, IsraelOTHER | 0 | Feb 13, 2018 | clinicaltrials |
| NCT03401827 | The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer | unknown | Phase 4 | 40 | Seoul National University HospitalOTHER | 1 | Feb 12, 2018 | clinicaltrials |
| NCT03214991 | Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer | unknown | — | 100 | Ji Kon RyuOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT02978547 | The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma(Metformin 001) | unknown | Phase 2 | 20 | British Columbia Cancer AgencyOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT02862015 | Multicenter RCT of the Clinical Effectiveness of Oncothermia With Chemotherapy in Metastatic Pancreatic Cancer Patients(Oncothermia) | unknown | Phase 2 | 100 | Seoul National University HospitalOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT03098160 | Immunotherapy Study of Evofosfamide in Combination With Ipilimumab | unknown | Phase 1 | 69 | Threshold PharmaceuticalsINDUSTRY | 1 | Oct 30, 2017 | clinicaltrials |
| NCT03317886 | Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer | unknown | Phase 3 | 354 | Wakayama Medical UniversityOTHER | 1 | Oct 24, 2017 | clinicaltrials |
| NCT03316326 | S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer | unknown | Phase 2 | 35 | National Taiwan University HospitalOTHER | 0 | Oct 20, 2017 | clinicaltrials |
| NCT03127150 | Chyle Leak After Pancreatic Operation | unknown | — | 1,000 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT03129607 | A Study in Postoperative Pancreatic Fistula | unknown | — | 300 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT02479984 | Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary Cancer | unknown | N/A | 193 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 14, 2017 | clinicaltrials |
| NCT01971281 | Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA) | unknown | Phase 1 / Phase 2 | 40 | NovoCure Ltd.INDUSTRY | 2 | Sep 13, 2017 | clinicaltrials |
| NCT03278015 | Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients | unknown | Phase 2 | 90 | Chinese PLA General HospitalOTHER | 1 | Sep 11, 2017 | clinicaltrials |
| NCT03269955 | The Effect of Application of TachoSil® in Pancreatoduodenectomy | unknown | Phase 4 | 126 | Asan Medical CenterOTHER | 1 | Sep 1, 2017 | clinicaltrials |
| NCT03267173 | Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer. | unknown | Early Phase 1 | 10 | First Affiliated Hospital of Harbin Medical UniversityOTHER | 1 | Aug 30, 2017 | clinicaltrials |
| NCT01563133 | Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas(CONTACT) | unknown | N/A | 330 | Mauna Kea TechnologiesINDUSTRY | 1 | Aug 29, 2017 | clinicaltrials |
| NCT03167112 | A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer(Folfirinox) | unknown | Phase 2 | 20 | Petr KavanOTHER | 1 | Aug 29, 2017 | clinicaltrials |
| NCT03251365 | Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer | unknown | Phase 2 / Phase 3 | 42 | Hospital General de Ciudad RealOTHER | 1 | Aug 16, 2017 | clinicaltrials |
| NCT03236883 | Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic Cancer(HST) | unknown | Phase 1 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Aug 2, 2017 | clinicaltrials |
| NCT02823678 | Pancreas Volume and Diabetes Status Following Pancreatectomy | unknown | — | 100 | Florida Hospital Tampa Bay DivisionOTHER | 0 | Jul 28, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Oct 11, 2018source: clinicaltrials